Successful pregnancy in a patient with Fabry disease and predominant renal involvement


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This case report presents a rare in obstetric practice observation of the course of pregnancy in a patient with Fabry disease. It illustrates the difficulty of diagnosis, distinguishing features of clinical manifestations and course of the disease during pregnancy. The case shows the opportunity of a favorable outcome for the mother and the fetus, provided that timely diagnosis is made and enzyme replacement therapy is given.

Full Text

Restricted Access

References

  1. Desnic R.J., Ioannou Y., Eng С.М. Alpha-Galactosidase A deficiency: Fabry disease. In: Scriver C.R., Sly W.S., Valle D., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. N.Y.: McGraw-Hill, 2001. P. 3733-3774.
  2. Meikle P.J., Hopwood J.J., Clague A.E., Carey W.F. Prevalence of lysosomal storage disorders. JAMA. 1999; 281: 249-254.
  3. Maier E.M., Osterrieder S., Whybra C., Ries M., Gal A., Beck M., Roscher A.A., Muntau A.C. Disease manifestations and X inactivation in heterozygous females with Fabry disease. Acta. Paediatr. 2006; 95(451): 30-38.
  4. Van der Tol L., Smid B.E., Poorthuis B.J., Biegstraaten M., Deprez R.H., Linthorst G.E., Hollak C.E. A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J. Med. Genet. 2014; 51(1): 1-9.
  5. Dehout F., Roland D., Henry F., Teichmann E., Beck M. Successful pregnancy in a patient with Fabry disease receiving enzyme replacement therapy. Acta. Paediatr. 2006; 451: 137-138.
  6. Kalkum G., Macchiella D., Reinke J., Kölbl H., Beck M. Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009; 144: 92- 96.
  7. Wendt S., Whybra C., Kampmann C., Teichmann E., Beck M. Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa. J. Inherit. Metab. Dis. 2005; 28: 787-788.
  8. Волгина С.Я. Болезнь Фабри: лекция для врачей. Практическая медицина. 2012; 7(62): 75- 79.
  9. Clark J. T.R. Narrative Review: Fabry disease. Ann. Intern. Med. 2007; 146: 425-433.
  10. Zarate Y.A., Hopkin R.J. Fabry Disease. Lancet. 2008; 372: 1427-1435.
  11. Фомин В.В., Пулин А.А., Мухин Н.А. Нефропатия при болезни Фабри: возможности радикального улучшения прогноза при орфанных заболеваниях. Терапевтический архив. 2013; 6: 4-9.
  12. Sessa A., Meroni M., Battini G., Righetti M., Nebuloni M., Tosoni A., Vago G.L. Sudio Multicentrico Italiano sulla Malattia di Anderson-Fabry. Studio Multicentrico Italiano sulla Malattia di Anderson-Fabri. Evolution of renal pathology in Fabry disease. Acta. Paediatr. Suppl. 2003; 92(443): 6-8.
  13. Фомин В.В., Пулин А.А., Аксенова О.А., Кустова Т.Ю., Гирина С.С., Рощупкина С.В., Кудрявцев В.А., Варшавский В.А., Голицына Е.П., Дамулин И.В., Панасюк В.В., Мухин Н.А. Тяжелое поражение подоцитов, выявленное при электронной микроскопии почечного биоптата, у пациента с болезнью Фабри без выраженных изменений мочи и почечной недостаточности. Клиническая нефрология. 2012; 1: 55-58.
  14. Breunig F., Wanner C. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy. J. Nephrol. 2008; 21(1): 32-37.
  15. Grunfeld J., Lidove O., Joly D., Barbey F. Renal disease in Fabry patients. J. Inherit. Metab. Dis. 2001; 24: 71-74.
  16. Parent E., Wax J.R., Smith W., Blaszyk H., Pinette M.G., Cartin A., Blackstone J. Fabry disease complicating pregnancy. J. Matern. Fetal. Neonatal. Medicine. 2010; 23(10): 1253-1256.
  17. Vedder A.C., Strijland A., vd Bergh Weerman M.A., Florquin S., Aerts J.M., Hollak C.E. Manifestations of Fabry disease in placental tissue. J. Inherit. Metab. Dis. 2006; 29: 106-111.
  18. Whybra C., Miebach E., Mengel E., Gal A., Baron K., Beck M., Kampmann C. A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase alfa in 36 women with Fabry disease. Genet. Med. 2009; 11: 441-449.
  19. Thadhani R., Wolf M., West M.L., Tonelli M.,Ruthazer R.,Pastores G.M., Obrador G.T. Patients with Fabry disease on dialysis in the United States. Kidney International. 2002; 61: 249-255.
  20. Eng C.M., Germain D.P., Banikazemi M., Warnock D.G., Wanner C., Hopkin R.J., Bultas J., Lee P., Sims K., Brodie S.E., Pastores G.M., Strotmann J.M., Wilcox W.R. Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement. Genetic. Med. 2006; 8(9): 539-548.
  21. Mehta A., Ricci R., Widmer U., Dehout F., Garcia de Lorenzo A., Kampmann C., Linhart A., Sunder-Plassmann G., Ries M., Beck M. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur. J. Clin. Invest. 2004; 34: 236-242.
  22. Wanner C., Oliveira J.P., Ortiz A., Mauer M., Germain D.P.,Linthorst G.E., Serra A.L., Maródi L., Mignani R., Cianciaruso B., Vujkovac B., Lemay R., Beitner-Johnson D., Waldek S., Warnock D. G. Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry. Clin. J. Am. Soc. Nephrol. 2010; 5(12): 2220-2228.
  23. West M., Nicholls K., Mehta A., Clarke J.T., Steiner R., Beck M., Barshop B.A., Rhead W., Mensah R., Ries M., Schiffmann R. Agalsidase alfa and kidney dysfunction in Fabry disease. J. Am. Soc. Nephrol 2009; 20: 1132-1139.
  24. Реплагал. Инструкция по применению, противопоказания и состав. http://www.rlsnet.ru/tn_index_id_41773.htm
  25. Senocak Tasci E., Bicik Z. Safe and Successful Treatment With Agalsidase Beta During Pregnancy in Fabry Disease. Iran J Kidney Dis. 2015; 9(5): 406-408.
  26. Germain D.P., Bruneval P., Tran T.C., Balouet P., Richalet B., Benistan K. Uneventful pregnancy outcome after enzyme replacement therapy with agalsidase beta in a heterozygous female with Fabry disease: A case report. Eur. J. Med. Genet. 2010; 53(2): 111-112.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies